The essential role of the in situ immune reaction in human colorectal cancer
- PMID: 18559950
- DOI: 10.1189/jlb.1107773
The essential role of the in situ immune reaction in human colorectal cancer
Abstract
Colorectal cancer is the second most common cause of cancer-related death. Novel prognostic factors should be identified and validated to refine the present tumor-node-metastasis system. The presence of immune cells infiltrating colorectal cancers is a common phenomenon. However, the current belief is that clinically detectable human tumors escaping immune surveillance are no longer kept in check by the immune cells of the tumor microenvironment. Despite studies showing the influence of immune cell infiltrates on the behavior of colorectal carcinomas, this parameter is not currently recognized as a reliable prognostic factor. We showed that the nature, functional orientation, density, and location of immune cells within distinct tumor regions could provide a prognostic factor superior to and independent of criteria related to the anatomic extent of the tumor. The strength of the immune reaction identified in our studies could advance our understanding of cancer evolution and have important consequences for clinical practice.
Similar articles
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.Science. 2006 Sep 29;313(5795):1960-4. doi: 10.1126/science.1129139. Science. 2006. PMID: 17008531
-
Coordination of intratumoral immune reaction and human colorectal cancer recurrence.Cancer Res. 2009 Mar 15;69(6):2685-93. doi: 10.1158/0008-5472.CAN-08-2654. Epub 2009 Mar 3. Cancer Res. 2009. PMID: 19258510
-
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.J Clin Oncol. 2011 Feb 20;29(6):610-8. doi: 10.1200/JCO.2010.30.5425. Epub 2011 Jan 18. J Clin Oncol. 2011. PMID: 21245428
-
The adaptive immunologic microenvironment in colorectal cancer: a novel perspective.Cancer Res. 2007 Mar 1;67(5):1883-6. doi: 10.1158/0008-5472.CAN-06-4806. Cancer Res. 2007. PMID: 17332313 Review.
-
Immune infiltration in human tumors: a prognostic factor that should not be ignored.Oncogene. 2010 Feb 25;29(8):1093-102. doi: 10.1038/onc.2009.416. Epub 2009 Nov 30. Oncogene. 2010. PMID: 19946335 Review.
Cited by
-
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis.Oncotarget. 2015 Aug 21;6(24):20058-69. doi: 10.18632/oncotarget.2780. Oncotarget. 2015. PMID: 25595911 Free PMC article.
-
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.Nat Rev Cancer. 2020 Nov;20(11):662-680. doi: 10.1038/s41568-020-0285-7. Epub 2020 Aug 4. Nat Rev Cancer. 2020. PMID: 32753728 Review.
-
Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients.Cancer Immunol Immunother. 2010 Oct;59(10):1457-65. doi: 10.1007/s00262-010-0868-3. Epub 2010 Jun 1. Cancer Immunol Immunother. 2010. PMID: 20514541 Free PMC article.
-
Tumor-infiltrating lymphocytes in the immunotherapy era.Cell Mol Immunol. 2021 Apr;18(4):842-859. doi: 10.1038/s41423-020-00565-9. Epub 2020 Nov 2. Cell Mol Immunol. 2021. PMID: 33139907 Free PMC article. Review.
-
Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans.PLoS One. 2016 Jun 16;11(6):e0156660. doi: 10.1371/journal.pone.0156660. eCollection 2016. PLoS One. 2016. PMID: 27310868 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical